QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
The | |||
The | ||||
The |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Page |
||||
1 | ||||
1 | ||||
2 | ||||
3 | ||||
4 | ||||
5 | ||||
15 | ||||
17 | ||||
17 | ||||
18 | ||||
18 | ||||
19 | ||||
19 | ||||
19 | ||||
19 | ||||
20 | ||||
21 |
September 30, 2021 |
December 31, 2020 |
|||||||
(unaudited) | ||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | — | |||||
Prepaid expenses and other current assets |
— | |||||||
|
|
|
|
|||||
Total Current Assets |
— | |||||||
Deferred offering costs |
— | |||||||
Investments held in Trust Account |
— | |||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | — | |||||
Accrued offering costs |
— | |||||||
Promissory note – related party |
— | |||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Deferred underwriting fee payable |
— | |||||||
Warrant liabilities |
— | |||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption |
— | |||||||
Shareholders’ (Deficit) Equity |
||||||||
Preference shares, $ |
— | |||||||
Class A ordinary shares, $ |
|
|
|
|
|
|
— |
|
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
— | |||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Shareholders’ (Deficit) Equity |
( |
) |
||||||
|
|
|
|
|||||
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
$ |
$ |
||||||
|
|
|
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from August 31, 2020 (Inception) through September 30, 2020 |
||||||||||
General and administrative expenses |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) |
( |
) |
( |
) | ||||||
Other income (expense): |
||||||||||||
Income earned on investments held in Trust Account |
— | |||||||||||
Interest expense |
( |
) | ( |
) | — | |||||||
Transaction costs allocated to warrant liabilities |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
Change in fair value of warrant liabilities |
— | |||||||||||
|
|
|
|
|
|
|||||||
Total other income, net |
— | |||||||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ |
$ |
$ |
( |
) | |||||||
|
|
|
|
|
|
|||||||
Weighted average shares outstanding, Class A ordinary shares |
— | |||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class A ordinary shares |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
|||||||
Basic weighted average shares outstanding, Class B ordinary shares |
||||||||||||
|
|
|
|
|
|
|||||||
Basic net income (loss) per share, Class B ordinary shares |
$ |
$ |
$ |
( |
) | |||||||
|
|
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ (Deficit) Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Cash paid in excess of fair value of Private Placement warrants |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
Accretion for Class A ordinary shares to redemption amount |
— |
— |
— |
— |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2021 |
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) | |||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – September 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — August 31, 2020 (Inception) |
$ |
$ | $ | $ | $ | |||||||||||||||||||||||
Issuance of Class B ordinary shares |
— | — | — | |||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – September 30, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2021 |
For the Period from August 31, 2020 (Inception) through September 30, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Payment of formation costs through issuance of Class B ordinary shares |
|
|
— |
|
|
|
|
|
Income earned on investments held in Trust Account |
( |
) | — | |||||
Change in fair value of warrant liabilities |
( |
) | — | |||||
Transaction costs related to warrant liabilities |
— | |||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses and other current assets |
( |
) | — | |||||
Accrued expenses |
— | |||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | — | |||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash into Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) |
— |
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
— | |||||||
Proceeds from sale of Private Placement Warrants |
— | |||||||
Repayment of promissory note - related party |
( |
) | — | |||||
Payment of offering costs |
( |
) | — | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
— | |||||||
Net Change in Cash |
— | |||||||
Cash – Beginning |
— | |||||||
|
|
|
|
|||||
Cash – Ending |
$ |
$ | — | |||||
|
|
|
|
|||||
Non-cash investing and financing activities: |
||||||||
Deferred underwriting fee payable |
$ | $ | — | |||||
|
|
|
|
|
|
|
|
|
Deferred offering costs included in accrued offering costs |
|
$ |
— |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Deferred offering costs paid through promissory note - related party |
|
$ |
— |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares |
|
$ |
— |
|
|
$ |
|
|
|
|
|
|
Balance Sheet as of January 22, 2021 (audited) |
As Previously Reported |
Adjustment |
As Revised |
|||||||||
Class A ordinary shares subject to possible redemption |
$ | $ | $ | |||||||||
Class A ordinary shares |
$ | $ | ( |
) | $ | — | ||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total Shareholders’ (Deficit) Equity |
$ | $ | ( |
) | $ | ( |
) |
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A ordinary shares issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A ordinary shares subject to possible redemption |
$ | |||
|
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period From August 31, 2020 (Inception) Through September 30, 2020 |
||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||
Basic and diluted net income (loss) per ordinary share |
||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||
Allocation of net income (loss), as adjusted |
$ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||
Denominator: |
||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Basic and diluted net income (loss) per ordinary share |
$ | $ | $ | $ | $ | $ | ( |
) |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; |
• | if, and only if, the closing price of the Class A ordinary shares equal or exceeds $10.00 per public share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption of the warrant holders; and |
• | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |||
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |||
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Level |
Fair Value |
|||||||||
Assets: |
||||||||||
September 30, 2021 |
Investment held in Trust Account - Money Market Fund |
1 |
$ |
|||||||
Liabilities: |
||||||||||
September 30, 2021 |
Warrant Liability – Public Warrants |
1 |
||||||||
September 30, 2021 |
Warrant Liability – Private Placement Warrants |
2 |
* | Filed herewith. |
TZP STRATEGIES ACQUISITION CORP. | ||||||
Date: November 12, 2021 | By: | /s/ Samuel Katz | ||||
Name: | Samuel Katz | |||||
Title: | Chief Executive Officer and Director | |||||
(Principal Executive Officer) | ||||||
Date: November 12, 2021 | By: | /s/ Sheera Michael | ||||
Name: | Sheera Michael | |||||
Title: | (Principal Financial Officer and | |||||
Principal Accounting Officer) |